Switch to:

Intercept Pharmaceuticals Inc (ICPT) Ownership Data

Short Interest History (%)

This is the historical short interest of Intercept Pharmaceuticals Inc, as measured by the Short Percentage Of Float.

Date Short Interest
June 15, 201521.46
May 29, 201522.39
May 15, 201520.6
April 30, 201520.05
April 15, 201519.63
March 31, 201526.61
March 13, 201528.12
February 27, 201527.85
February 13, 201527.3
January 30, 201529.5
January 15, 201529.59
December 31, 201427.28
December 15, 201424.04
November 28, 201421.93
November 14, 201421.72
October 31, 201415.35
October 15, 201410.31
September 30, 20149.2
September 15, 20147.75
August 29, 20146.34
August 15, 20146.05
July 31, 20148.07
July 15, 20147.21
June 30, 20148.18
June 13, 20149.71
May 30, 20149.8
May 15, 20147.57
April 30, 20145.65
April 15, 20144.25
March 31, 20146.07
March 14, 20149.48
February 28, 20149.52
February 14, 201410.44
January 31, 20149.41
January 15, 20148.95
December 31, 201313.32
December 13, 20138.64
November 29, 20138.36
November 15, 20135.58
October 31, 20134.64
October 15, 20135.25
September 30, 20133.52
September 13, 20133.68
August 30, 20133.47
August 15, 20133.17
July 31, 20133.15
July 15, 20133.67
June 28, 20132.85
June 14, 20132.76
May 31, 20132.8
May 15, 20133.03
April 30, 20133.46
April 15, 20133.54
March 28, 20133.89
March 15, 20133.74
February 28, 20133.7
February 15, 20133.3
January 31, 20132.47
January 15, 20132.76
December 31, 20123.37
December 14, 20120.27
November 30, 20120.13
November 15, 20120.16
October 31, 20120.05

Institutional Ownership History (%)

This the Institutional Ownership History of Intercept Pharmaceuticals IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
March 31, 201579
September 30, 201460
June 30, 201469
March 31, 201463
December 31, 201393
September 30, 201361
June 30, 201347
March 31, 201339
December 31, 201236

Insider ownership (%)

This is the historical insider ownership of Intercept Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
April 30, 20152
March 31, 20153
February 28, 20153
January 31, 20153
December 31, 20142
November 30, 20143
October 31, 20143
September 30, 20143
August 31, 20143
July 31, 20143
June 30, 20143
May 31, 20143

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Mr. Mark Pruzanski, M.D.CEO & President502,3042.09%2015-06-03
Mr. David Shapiro, M.D.CMO and EVP - Development18,514less than 0.1%2015-06-15
Ms. Barbara G. DuncanCFO17,523less than 0.1%2015-04-01
Dr. Luciano Adorini, M.D.Chief Scientific Officer10,060less than 0.1%2015-06-08
Mr. Paolo FundaroDirector8,803less than 0.1%2014-08-09
Dr. Srinivas Akkaraju,M.D.Director8,642less than 0.1%2015-05-19
Ms. Lisa BrightN/A8,378less than 0.1%2015-02-17
Rachel McMinnN/A4,923less than 0.1%2014-04-30
Dr. Klaus Veitinger, M.D.Director2,166less than 0.1%2015-06-10
Dr. Luca Benatti, PhDDirector1,292less than 0.1%2014-12-15

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value
Genextra SpA6,454,9532014-12-3130.140.001,006,972,668
Fidelity Management and Research Company   Premium Plus3,528,3762015-03-3115.540.14995,073,000
OrbiMed Private Investments IV, LP1,654,6032014-05-307.850.00437,013,744
Carmignac Gestion   Premium Plus1,349,3872015-03-315.943.37380,554,000
Fidelity® Select Biotechnology Portfolio1,187,8682015-04-304.932.16300,304,909
Orbimed Advisors, LLC   Premium Plus1,120,0002015-03-314.932.70315,862,000
Vanguard Group, Inc.   Premium Plus954,5742015-03-314.200.02269,209,000
Columbia Mangmt Investment Advisers, LLC   Premium Plus823,6082015-03-313.630.15232,271,000
Hansard EU Carmignac Patrimoine805,9982015-05-313.350.65205,686,092
Capital World Investors   Premium Plus780,0002015-03-313.440.06219,976,000

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK